activity
20132026
most citedMonte Carlo based Designs for Constrained Domains

4 citations · 10 across the 23 of their papers we have counts for

collaborators

24 papers

stat.ME2026

Frequentist-calibrated Bayesian group sequential design with dynamic borrowing

Francesco Mariani, Shirin Golchi, Stefania Gubbiotti +1

Bayesian analysis is increasingly used in clinical trials. However, assessment of the design with respect to the frequentist operating characteristics, such as type I error and pow…

stat.ME2026

Bayesian Design and Analysis of Precision Trials with Partial Borrowing

Shirin Golchi, Satoshi Morita

With the advancement of precision medicine there is an increasing need for design and analysis methods in clinical trials with the objective of investigating effect heterogeneity a…

stat.ME2026

A Bayesian adaptive enrichment design using aggregate historical data to inform individualized treatment recommendations

Lara Maleyeff, Shirin Golchi, Erica E. M. Moodie

Adaptive enrichment trials aim to identify and recruit participants most likely to benefit from treatment based on evolving biomarker evidence, with the goal of informing individua…

stat.ME2025

Bayesian Design of Experiments in the Presence of Nuisance Parameters

Shirin Golchi, Luke Hagar

Design of experiments has traditionally relied on the frequentist hypothesis testing framework where the optimal size of the experiment is specified as the minimum sample size that…

stat.ME2025

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials

Xianglin Zhao, Shirin Golchi, Jean-Philippe Gouin +1

Treatment effect heterogeneity refers to the systematic variation in treatment effects across subgroups. There is an increasing need for clinical trials that aim to investigate tre…

stat.ME2025

An Efficient Approach to Design Bayesian Platform Trials

Luke Hagar, Lara Maleyeff, Shirin Golchi +1

Platform trials evaluate multiple experimental treatments against a common control group (and/or against each other), which often reduces the trial duration and sample size. Bayesi…

stat.AP2025

The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods

Lara Maleyeff, Valérie Leclair, Shirin Golchi +1

Pilot feasibility studies play a pivotal role in the development of clinical trials for rare diseases, where small populations and slow recruitment often threaten trial viability.…

math.GR2025

Classifying group actions on hyperbolic spaces

D. Osin, K. Oyakawa, A. Rapinchuk

For a given group , it is natural to ask whether one can classify all isometric -actions on Gromov hyperbolic spaces. We propose a formalization of this problem utilizing the…

stat.AP2025

A Precision Trial Case Study for Heterogeneous Treatment Effects in Obstructive Sleep Apnea

Lara Maleyeff, Shirin Golchi, Erica E. M. Moodie +1

Precision medicine tailors treatments to individual patient characteristics, which is especially valuable for conditions like obstructive sleep apnea (OSA), where treatment respons…

stat.ME2025

fkbma: An R Package for Detecting Tailoring Variables with Free-Knot B-Splines and Bayesian Model Averaging

Lara Maleyeff, Shirin Golchi, Erica E. M. Moodie

Precision medicine aims to optimize treatment by identifying patient subgroups most likely to benefit from specific interventions. To support this goal, we introduce fkbma, an R pa…

stat.ME2025

Design of Bayesian Clinical Trials with Clustered Data

Luke Hagar, Shirin Golchi

In the design of clinical trials, it is essential to assess the design operating characteristics (e.g., power and the type I error rate). Common practice for the evaluation of oper…

stat.ME2024

Sparse two-stage Bayesian meta-analysis for individualized treatments

Junwei Shen, Erica E. M. Moodie, Shirin Golchi

Individualized treatment rules tailor treatments to patients based on clinical, demographic, and other characteristics. Estimation of individualized treatment rules requires the id…

stat.ME2024

An adaptive enrichment design using Bayesian model averaging for selection and threshold-identification of tailoring variables

Lara Maleyeff, Shirin Golchi, Erica E. M. Moodie +1

Precision medicine stands as a transformative approach in healthcare, offering tailored treatments that can enhance patient outcomes and reduce healthcare costs. As understanding o…

stat.ME2024

Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials

James Willard, Shirin Golchi, Erica EM Moodie

Early phase, personalized dose-finding trials for combination therapies seek to identify patient-specific optimal biological dose (OBD) combinations, which are defined as safe dose…

stat.ME2023

Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies

James Willard, Shirin Golchi, Erica E. M. Moodie +2

Identification of optimal dose combinations in early phase dose-finding trials is challenging, due to the trade-off between precisely estimating the many parameters required to fle…

stat.ME2023

Estimating the Sampling Distribution of Posterior Decision Summaries in Bayesian Clinical Trials

Shirin Golchi, James Willard

Bayesian inference and the use of posterior or posterior predictive probabilities for decision making have become increasingly popular in clinical trials. The current practice in B…

stat.ME2022

Covariate Adjustment in Bayesian Adaptive Randomized Controlled Trials

James Willard, Shirin Golchi, Erica EM Moodie

In conventional randomized controlled trials, adjustment for baseline values of covariates known to be at least moderately associated with the outcome increases the power of the tr…

stat.ME2022

New designs for Bayesian adaptive cluster-randomized trials

Junwei Shen, Shirin Golchi, Erica E. M. Moodie +1

Adaptive approaches, allowing for more flexible trial design, have been proposed for individually randomized trials to save time or reduce sample size. However, adaptive designs fo…

stat.ME2021

Estimating Design Operating Characteristics in Bayesian Adaptive Clinical Trials

Shirin Golchi

Bayesian adaptive designs have gained popularity in all phases of clinical trials with numerous new developments in the past few decades. During the COVID-19 pandemic, the need to…

stat.AP2020★ 2 cited

Use of Historical Individual Patient Data in Analysis of Clinical Trials

Shirin Golchi

Historical data from previous clinical trials, observational studies and health records may be utilized in analysis of clinical trials data to strengthen inference. Under the Bayes…

stat.ME2015★ 4 cited

Monte Carlo based Designs for Constrained Domains

Shirin Golchi, Jason L. Loeppky

Space filling designs are central to studying complex systems in various areas of science. They are used for obtaining an overall understanding of the behaviour of the response ove…

stat.AP2015★ 1 cited

A Bayesian Search for the Higgs Particle

Shirin Golchi, Richard Lockhart

The statistical procedure used in the search for the Higgs boson is investigated in this paper. A Bayesian hierarchical model is proposed that uses the information provided by the…

stat.ME2014

Sequentially Constrained Monte Carlo

Shirin Golchi, David A. Campbell

Constraints can be interpreted in a broad sense as any kind of explicit restriction over the parameters. While some constraints are defined directly on the parameter space, when th…

stat.ME2013★ 3 cited

Monotone Function Estimation for Computer Experiments

Shirin Golchi, Derek R. Bingham, Hugh Chipman +1

In statistical modeling of computer experiments sometimes prior information is available about the underlying function. For example, the physical system simulated by the computer c…